The luxury country estate grows by 58 additional rooms and suites, 12 cottages and a serene…
Categoría: Business Wire
Category Added in a WPeMatico Campaign
Lifestyle Brand CORE Named Title Sponsor of the Formula E 2023 CORE Diriyah E-Prix
RIYADH, Saudi Arabia–(BUSINESS WIRE)–Introducing the 2023 CORE Diriyah E-Prix! The title sponsor of the ABB FIA…
Sphering Group Acquires EKA in Germany to Become the EU Market Maker in Chimney & Flue Systems
RENNES, France–(BUSINESS WIRE)–Sphering announces the most important acquisition in the Group history with eka-edelstahlkamine, founded 37…
Juniper Research: Future Digital Award Winners Announced for Telco Innovation 2023
BASINGSTOKE, England–(BUSINESS WIRE)–It is with great pleasure that Juniper Research announces the 2023 winners of the…
Poxel Receives Orphan Drug Designation from the European Commission for PXL770 and PXL065 for Treatment of Adrenoleukodystrophy
LYON, France–(BUSINESS WIRE)–POXEL SA (Euronext : POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative…
Lysogene: Conversion of the Safeguard Proceedings Into Reorganization Proceedings
PARIS–(BUSINESS WIRE)–Regulatory News: Lysogene (FR0013233475 – LYS) (Paris:LYS), a phase 3 gene therapy platform Company targeting…
Innate Pharma Announces HSR Clearance Regarding Expansion of Its Collaboration With Sanofi on NK Cell Engagers
Following expiration of Hart-Scott-Rodino waiting period regarding expansion of their collaboration on NK cell engagers, the…
MetricStream Named Chartis Research RiskTech100 2023 Category Winner for Enterprise GRC, Audit and GRC Domain Specific Language
LONDON–(BUSINESS WIRE)–MetricStream, the global market leader of integrated risk management and governance, risk, and compliance (GRC),…
Techstars, MCIT, RAED Ventures and Saudi National Bank Announce the Continuation of The Riyadh Techstars Accelerator
The program is now accepting applications and will help drive more innovation and entrepreneurship in the…
Memo Therapeutics AG Announces Positive Phase I Data with AntiBKV for Treatment of BKV Infection in Renal Transplant Patients
Clinical trial met primary endpoint of safety and tolerability IND submission planned in Q1 2023 to…